dokumendiregister.ee
Väljaminev kiriAvalik

Euroopa farmakopöa töökava asjus

Ravimiamet · 25. september 2024
Viit
REP-1/3446-2
Registreeritud
25. september 2024
Dokumendi liik
Väljaminev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2024
Vastutaja
Signe Leito (RA, Labor)

Failid

Sisu (failidest)

Survey for information on approved products containing anhydrous ephedrine, ephedrine hemihydrate or ephedrine hydrochloride, racemic page 1 / 5 Q1-3 (3566) NPA: (47330) Type: (!/list-dropdown) A10 - Estonia (EE) Is Ephedrine (0488, anhydrous base) used in approved products in your country? (47331) Type: (L/list-radio) No A3 page 2 / 5 Please list the names of any approved products in your country containing Ephedrine (0488) and the contact details of any corresponding MAH(s) or information on substance manufacturers. (47332) Type: (T/text-long) n.a Is Ephedrine hemihydrate (0489) used in approved products in your country? (47336) Type: (L/list-radio) No AO03 Please list the names of any approved products in your country containing Ephedrine hemihydrate (0489) and the contact details of any corresponding MAH(s) or information on substance manufacturers. (47333) Type: (T/text-long) n.a page 3 / 5 Is racemic Ephedrine hydrochloride (0715, anhydrous) used in approved products in your country? (47337) Type: (L/list-radio) No AO02 Please list the names of any approved products in your country containing Ephedrine hydrochloride, racemic (0715) and the contact details of any corresponding MAH(s) or information on substance manufacturers. (47334) Type: (T/text-long) n.a Comments: (47335) Type: (T/text-long) - page 4 / 5 page 5 / 5
Allikas: Ravimiamet dokumendiregister →